Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The hydrogen-potassium ATPase alpha subunit is the catalytic component of the gastric proton pump that exchanges cytoplasmic hydronium ions for extracellular potassium ions via ATP hydrolysis, serving as the final step in gastric acid secretion. It is encoded by the ATP4A gene and structurally consists of approximately 1,000 amino acids, incorporating multiple transmembrane domains. The enzyme functions as an α,β-heterodimer with the β subunit stabilizing and targeting the complex to the membrane. This ATPase is the principal target for proton pump inhibitors (PPIs), which revolutionized the treatment of peptic ulcer disease and acid reflux disorders by blocking acid secretion at its source.
Inhibition of gastric acid secretion by covalent or competitive binding to the pump, blocking the catalytic cycle and ion transport. Irreversible inhibition (PPIs covalently modify the enzyme). Reversible inhibition (potassium-competitive inhibitors).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hydrogen-potassium ATPase alpha subunit (H+/K+ ATPase alpha subunit).